Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shot up 21.6% on Monday . The company traded as high as GBX 2.35 ($0.03) and last traded at GBX 2.34 ($0.03). 3,196,030 shares traded hands during trading, an increase of 143% from the average session volume of 1,317,947 shares. The stock had previously closed at GBX 1.93 ($0.02).
Cizzle Biotechnology Stock Down 4.0 %
The firm has a 50 day simple moving average of GBX 1.86 and a 200-day simple moving average of GBX 1.80. The company has a market cap of £8.00 million, a PE ratio of -218.00 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- 3 Monster Growth Stocks to Buy Now
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
